Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1864 1
1869 1
1873 1
1874 1
1875 1
1877 1
1879 1
1882 1
1886 1
1890 1
1897 2
1902 2
1904 1
1908 2
1909 1
1910 1
1911 2
1912 5
1913 3
1914 6
1915 2
1918 1
1919 2
1920 2
1921 1
1923 1
1924 1
1925 2
1926 1
1930 7
1931 3
1932 6
1934 5
1935 4
1936 2
1937 1
1938 1
1940 1
1942 2
1943 1
1944 2
1945 15
1946 39
1947 27
1948 19
1949 19
1950 36
1951 31
1952 44
1953 45
1954 44
1955 30
1956 34
1957 37
1958 40
1959 39
1960 48
1961 65
1962 38
1963 122
1964 136
1965 101
1966 116
1967 100
1968 133
1969 120
1970 145
1971 159
1972 141
1973 150
1974 130
1975 120
1976 123
1977 143
1978 152
1979 199
1980 182
1981 197
1982 207
1983 213
1984 286
1985 276
1986 263
1987 317
1988 289
1989 302
1990 339
1991 322
1992 288
1993 340
1994 327
1995 351
1996 344
1997 345
1998 383
1999 444
2000 421
2001 478
2002 502
2003 513
2004 494
2005 486
2006 505
2007 537
2008 569
2009 556
2010 664
2011 670
2012 798
2013 913
2014 863
2015 918
2016 939
2017 1056
2018 1182
2019 1223
2020 564
Text availability
Article attribute
Article type
Publication date

Search Results

22,366 results
Results by year
Filters applied: . Clear all
Page 1
Histopathology of alopecia: a clinicopathological approach to diagnosis.
Stefanato CM. Stefanato CM. Histopathology. 2010 Jan;56(1):24-38. doi: 10.1111/j.1365-2559.2009.03439.x. Histopathology. 2010. PMID: 20055903 Review.
Interpretation of the histopathological findings of primary scarring and non-scarring alopecias may prove daunting. This is especially true if the biopsy specimen is inadequate, and the clinical history and pattern of the alopecia are not known. ...The non-scarring …
Interpretation of the histopathological findings of primary scarring and non-scarring alopecias may prove daunting. This is especiall …
Safety concerns when using novel medications to treat alopecia.
Almohanna HM, Perper M, Tosti A. Almohanna HM, et al. Expert Opin Drug Saf. 2018 Nov;17(11):1115-1128. doi: 10.1080/14740338.2018.1533549. Epub 2018 Oct 25. Expert Opin Drug Saf. 2018. PMID: 30318935 Review.
Alopecia is often a cause of great concern to patients for cosmetic and psychologic reasons. The aim of treating non-scarring alopecias is to reduce hair loss and, to some extent, enhance hair regrowth. However, therapies for scarring alopecias are limited an
Alopecia is often a cause of great concern to patients for cosmetic and psychologic reasons. The aim of treating non-scarring alop
Cicatricial alopecia.
Kanti V, Röwert-Huber J, Vogt A, Blume-Peytavi U. Kanti V, et al. J Dtsch Dermatol Ges. 2018 Apr;16(4):435-461. doi: 10.1111/ddg.13498. J Dtsch Dermatol Ges. 2018. PMID: 29645394 Review.
While most forms of cicatricial alopecia can be clearly diagnosed based on clinical presentation in the acute disease stage, diagnosis can be challenging in the subacute, early or late disease stages. ...Anti-inflammatory treatment with topical corticosteroids class III to …
While most forms of cicatricial alopecia can be clearly diagnosed based on clinical presentation in the acute disease stage, diagnosi …
Off-Label Use of Topical Minoxidil in Alopecia: A Review.
Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S. Stoehr JR, et al. Am J Clin Dermatol. 2019 Apr;20(2):237-250. doi: 10.1007/s40257-018-0409-y. Am J Clin Dermatol. 2019. PMID: 30604379 Review.
Conditions for which the use of topical minoxidil has been reported include telogen effluvium, alopecia areata (AA), scarring alopecia, eyebrow hypotrichosis, monilethrix, and chemotherapy-induced alopecia (CIA). ...For certain conditions, including AA and mo …
Conditions for which the use of topical minoxidil has been reported include telogen effluvium, alopecia areata (AA), scarring alop
Traction alopecia: A neglected entity in 2017.
Akingbola CO, Vyas J. Akingbola CO, et al. Indian J Dermatol Venereol Leprol. 2017 Nov-Dec;83(6):644-649. doi: 10.4103/ijdvl.IJDVL_553_16. Indian J Dermatol Venereol Leprol. 2017. PMID: 29035284 Free article. Review.
Traction alopecia was first described in 1904 but is still a cause of scarring hair loss in young women worldwide. It is unique in being initially a reversible then an irreversible (scarring) form of alopecia. ...There are some new examination findings associated wi …
Traction alopecia was first described in 1904 but is still a cause of scarring hair loss in young women worldwide. It is unique in be …
A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. Lee SW, et al. J Drugs Dermatol. 2018 Apr 1;17(4):457-463. J Drugs Dermatol. 2018. PMID: 29601622 Free PMC article. Review.
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of androgenetic alopecia. ...Continued research into drug-delivery, ideal topic …
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administration (FDA) and …
Pathomechanisms of immune-mediated alopecia.
Anzai A, Wang EHC, Lee EY, Aoki V, Christiano AM. Anzai A, et al. Int Immunol. 2019 Jul 13;31(7):439-447. doi: 10.1093/intimm/dxz039. Int Immunol. 2019. PMID: 31050755 Free PMC article. Review.
When this IP collapses, inflammatory infiltrates that aggregate around the bulge and bulb launch an immune attack on the HF, resulting in hair loss or alopecia. Alopecia areata (AA) and primary cicatricial alopecia (PCA) are two common forms of immune-mediate …
When this IP collapses, inflammatory infiltrates that aggregate around the bulge and bulb launch an immune attack on the HF, resulting in ha …
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.
Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, Trakatelli M, Finner A, Kiesewetter F, Trüeb R, Rzany B, Blume-Peytavi U; European Dermatology Forum (EDF). Blumeyer A, et al. J Dtsch Dermatol Ges. 2011 Oct;9 Suppl 6:S1-57. doi: 10.1111/j.1610-0379.2011.07802.x. J Dtsch Dermatol Ges. 2011. PMID: 21980982
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. ...Patients diagnosed with androgenet …
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia
Primary cicatricial alopecia: Other lymphocytic primary cicatricial alopecias and neutrophilic and mixed primary cicatricial alopecias.
Bolduc C, Sperling LC, Shapiro J. Bolduc C, et al. J Am Acad Dermatol. 2016 Dec;75(6):1101-1117. doi: 10.1016/j.jaad.2015.01.056. J Am Acad Dermatol. 2016. PMID: 27846945 Review.
Primary cicatricial alopecias can be frustrating for both patients and physicians. Proper diagnosis guides more successful management of these challenging conditions. Part II will cover the remaining lymphocytic primary cicatricial alopecias, which include pseudopel …
Primary cicatricial alopecias can be frustrating for both patients and physicians. Proper diagnosis guides more successful management …
Diagnosis and management of alopecia in children.
Castelo-Soccio L. Castelo-Soccio L. Pediatr Clin North Am. 2014 Apr;61(2):427-42. doi: 10.1016/j.pcl.2013.12.002. Epub 2014 Jan 21. Pediatr Clin North Am. 2014. PMID: 24636654 Review.
There are 5 common types of hair loss in children: alopecia related to tinea capitis, alopecia areata spectrum/autoimmune alopecia, traction alopecia, telogen effluvium, and trichotillomania/trichotillosis. ...Rarer reasons for alopecia in child …
There are 5 common types of hair loss in children: alopecia related to tinea capitis, alopecia areata spectrum/autoimmune a
22,366 results
Jump to page
Feedback